Publications

Export 53 results:
Author Title Type [ Year(Asc)]
Filters: Author is John CS Breitner  [Clear All Filters]
2017
Breitner JCS.  2017.  Comment: MCI trials-Categorical "square pegs" in dimensional "round holes"? Neurology. 88(18):1757.
Tuwaig M, Savard M, Jutras B, Poirier J, D Collins L, Rosa-Neto P, Fontaine D, Breitner JCS.  2017.  Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.. J Alzheimers Dis. 60(4):1589-1600.
Krysinska K, Sachdev PS, Breitner JCS, Kivipelto M, Kukull W, Brodaty H.  2017.  Dementia registries around the globe and their applications: A systematic review.. Alzheimers Dement.
Maysinger D, Ji J, Moquin A, Hossain S, Hancock MA, Zhang I, K Y Chang P, Rigby M, Anthonisen M, Grütter P et al..  2017.  Dendritic Polyglycerol Sulfates in the Prevention of Synaptic Loss and Mechanism of Action on Glia.. ACS Chem Neurosci.
Lafaille-Magnan M-E, Poirier J, Etienne P, Tremblay-Mercier J, Frenette J, Rosa-Neto P, Breitner JCS.  2017.  Odor identification as a biomarker of preclinical AD in older adults at risk.. Neurology. 89(4):327-335.
Verfaillie SCJ, Binette APichet, Vachon-Presseau E, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JCS et al..  2017.  Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer’s Disease.
Dadar M, Pascoal TA, Manitsirikul S, Misquitta K, Tartaglia C, Breitner JCS, Rosa-Neto P, Carmichael O, DeCarli C, D Collins L.  2017.  Validation of a Regression Technique for Segmentation of White Matter Hyperintensities in Alzheimer's Disease.. IEEE Trans Med Imaging.
2016
Leoutsakos J-M, Gross AL, Jones RN, Albert MS, Breitner JCS.  2016.  'Alzheimer's Progression Score': Development of a Biomarker Summary Outcome for AD Prevention Trials.. J Prev Alzheimers Dis. 3(4):229-235.
Tam A, Dansereau C, Badhwar AP, Orban P, Belleville S, Chertkow H, Dagher A, Hanganu A, Monchi O, Rosa-Neto P et al..  2016.  A dataset of multiresolution functional brain parcellations in an elderly population with no or mild cognitive impairment.. Data Brief. 9:1122-1129.
Cavanagh C, Tse YChung, Nguyen H-B, Krantic S, Breitner JCS, Quirion R, Wong TPan.  2016.  Inhibiting tumor necrosis factor-α before amyloidosis prevents synaptic deficits in an Alzheimer's disease model.. Neurobiol Aging. 47:41-49.
Breitner JCS, Poirier J, Etienne PE, Leoutsakos JM.  2016.  Rationale and Structure for a New Center for Studies on Prevention of Alzheimer's Disease (StoP-AD).. J Prev Alzheimers Dis. 3(4):236-242.
2015
Barucker C, Sommer A, Beckmann G, Eravci M, Harmeier A, Schipke CG, Brockschnieder D, Dyrks T, Althoff V, Fraser PE et al..  2015.  Alzheimer amyloid peptide aβ42 regulates gene expression of transcription and growth factors.. J Alzheimers Dis. 44(2):613-24.
Breitner JCS.  2015.  Comment: Yet another "disconnect" between amyloid and Alzheimer disease? Neurology. 85(8):698.
Tam A, Dansereau C, Badhwar AP, Orban P, Belleville S, Chertkow H, Dagher A, Hanganu A, Monchi O, Rosa-Neto P et al..  2015.  Common Effects of Amnestic Mild Cognitive Impairment on Resting-State Connectivity Across Four Independent Studies.. Front Aging Neurosci. 7:242.
Chuang Y-F, An Y, Bilgel M, Wong DF, Troncoso JC, O'Brien RJ, Breitner JCS, Ferruci L, Resnick SM, Thambisetty M.  2015.  Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation.. Mol Psychiatry.
Heneka MT, Carson MJ, Khoury JEl, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM et al..  2015.  Neuroinflammation in Alzheimer's disease.. Lancet Neurol. 14(4):388-405.
Breitner JCS.  2015.  Observations on DSM-5 Mild Neurocognitive Disorder vs. its predecessor, Mild Cognitive Impairment.. Acta Psychiatr Scand. 131(1):15-7.
Colby-Milley J, Cavanagh C, Jego S, Breitner JCS, Quirion R, Adamantidis A.  2015.  Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages.. PLoS One. 10(6):e0130177.
Orban P, Madjar C, Savard M, Dansereau C, Tam A, Das S, Evans AC, Rosa-Neto P, Breitner JCS, Bellec P.  2015.  Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer's disease.. Sci Data. 2:150043.
2014
Poirier J, Miron J, Picard C, Gormley P, Théroux L, Breitner JCS, Dea D.  2014.  Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease.. Neurobiol Aging. 35 Suppl 2:S3-10.
Luck T, Riedel-Heller SG, Luppa M, Wiese B, Bachmann C, Jessen F, Bickel H, Weyerer S, Pentzek M, König H-H et al..  2014.  A hierarchy of predictors for dementia-free survival in old-age: results of the AgeCoDe study.. Acta Psychiatr Scand. 129(1):63-72.
Breitner JCS.  2014.  Mild cognitive impairment and progression to dementia: new findings.. Neurology. 82(4):e34-5.
Zuo X-N, Anderson JS, Bellec P, Birn RM, Biswal BB, Blautzik J, Breitner JCS, Buckner RL, Calhoun VD, F Castellanos X et al..  2014.  An open science resource for establishing reliability and reproducibility in functional connectomics.. Sci Data. 1:140049.
Zimmer ERigon, Leuzy A, Benedet ALessa, Breitner JCS, Gauthier S, Rosa-Neto P.  2014.  Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.. J Neuroinflammation. 11:120.
Chuang Y-F, Breitner JCS, Chiu Y-L, Khachaturian A, Hayden K, Corcoran C, Tschanz J, Norton M, Munger R, Welsh-Bohmer K et al..  2014.  Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study.. Neurobiol Aging. 35(11):2429-35.

Pages